Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria E Goossens

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Vaccine|July 3, 2026
Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trialStéphanie Depickère, Pieter Pannus, Sarah Houben, et al.
NPJ Vaccines|March 9, 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variantKevin K Ariën, Leo Heyndrickx, Johan Michiels, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 12, 2021
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptomsMaria E Goossens, Kristof Y Neven, Pieter Pannus, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 25, 2021
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2David Triest, Laurence Geebelen, Robby De Pauw, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2016
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer TrialMaria E Goossens, Maurice P Zeegers, Hendrik van Poppel, et al.
BMC Urology|March 23, 2012
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in BelgiumMaria E Goossens, Frank Buntinx, Steven Joniau, et al.
European Journal of Nutrition|February 10, 2019
An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studiesWillem J A Witlox, Frits H M van Osch, Maree Brinkman, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Vaccine|July 3, 2026
Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trialStéphanie Depickère, Pieter Pannus, Sarah Houben, et al.
NPJ Vaccines|March 9, 2022
Three doses of BNT162b2 vaccine confer neutralising antibody capacity against the SARS-CoV-2 Omicron variantKevin K Ariën, Leo Heyndrickx, Johan Michiels, et al.
Archives of Public Health = Archives Belges De Sante Publique|November 12, 2021
The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptomsMaria E Goossens, Kristof Y Neven, Pieter Pannus, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|July 25, 2021
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2David Triest, Laurence Geebelen, Robby De Pauw, et al.
Cancer Cell|February 16, 2022
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipientsLorenzo Canti, Kevin K Ariën, Isabelle Desombere, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 11, 2023
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipientsDelphine Kemlin, Nicolas Gemander, Stéphanie Depickère, et al.
Journal of Hematology & Oncology|October 25, 2021
Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipientsLorenzo Canti, Stéphanie Humblet-Baron, Isabelle Desombere, et al.
European Journal of Cancer (Oxford, England : 1990)|November 5, 2016
Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer TrialMaria E Goossens, Maurice P Zeegers, Hendrik van Poppel, et al.
BMC Urology|March 23, 2012
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in BelgiumMaria E Goossens, Frank Buntinx, Steven Joniau, et al.
European Journal of Nutrition|February 10, 2019
An inverse association between the Mediterranean diet and bladder cancer risk: a pooled analysis of 13 cohort studiesWillem J A Witlox, Frits H M van Osch, Maree Brinkman, et al.
Pageof 4